Differential involvement of RalA and RalB in colorectal cancer

Small GTPases

Volumn 3, Issue 2, 2012, Pages 126-130

  Martin, Timothy D ^a   Der, Channing J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Colorectal cancer; Exocyst; Ral guanine nucleotide exchange factors; RalA; RalB; RalBP1; Ras

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; K RAS PROTEIN; MUTANT PROTEIN; RAL PROTEIN; RALA PROTEIN; RALB PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ANCHORAGE; COLORECTAL CANCER; DOWN REGULATION; EVIDENCE BASED MEDICINE; HUMAN; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MUTATION RATE; PANCREAS ADENOCARCINOMA; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84861504047     PISSN: 21541248     EISSN: 21541256     Source Type: Journal    
DOI: 10.4161/sgtp.19571     Document Type: Article

References (25)

1. Baines AT, Xu D, Der CJ. Inhibition of Ras for cancer treatment: the search continues. Future Med Chem 2011; 3:1787-808; PMID:22004085; http://dx.doi.org/10.4155/fmc.11.121.
2. Scholl C, Fröhling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009; 137:821-34; PMID:19490892; http://dx.doi.org/10.1016/j.cell.2009.03.017.
3. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137:835-48; PMID:19490893; http://dx.doi.org/10.1016/j.cell.2009.05.006.
4. Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N, et al. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 2009; 15:489-500; PMID:19477428; http://dx.doi.org/10.1016/j.ccr.2009.03.022.
5. Neel NF, Martin TD, Stratford JK, Zand TP, Reiner DJ, Der CJ. The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery. Genes Cancer 2011; 2:275-87; PMID:21779498; http://dx.doi.org/10.1177/1947601911407329.
6. Shirakawa R, Fukai S, Kawato M, Higashi T, Kondo H, Ikeda T, et al. Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPases. J Biol Chem 2009; 284:21580-8; PMID:19520869; http://dx.doi.org/10.1074/jbc.M109.012112.
7. Chen XW, Leto D, Xiong T, Yu G, Cheng A, Decker S, et al. A Ral GAP complex links PI 3-kinase/Akt signaling to RalA activation in insulin action. Mol Biol Cell 2011; 22:141-52; PMID:21148297; http://dx.doi.org/10.1091/mbc.E10-08-0665.
8. Mott HR, Owen D. RLIP76 (RalBP1): The first piece of the structural puzzle. Small Gtpases 2010; 1:157-60; PMID:21686269; http://dx.doi.org/10.4161/sgtp.1.3.14233.
9. Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 2005; 7:533-45; PMID:15950903; http://dx.doi.org/10.1016/j.ccr.2005.04.030.
10. Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, et al. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 2006; 16:2385-94; PMID:17174914; http://dx.doi.org/10.1016/j.cub.2006.10.023.
11. Chien Y, White MA. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep 2003; 4:800-6; PMID:12856001; http://dx.doi.org/10.1038/sj.embor.embor899.
12. Martin TD, Samuel JC, Routh ED, Der CJ, Yeh JJ. Activation and involvement of Ral GTPases in colorectal cancer. Cancer Res 2011; 71:206-15; PMID:21199803; http://dx.doi.org/10.1158/0008-5472.CAN-10-1517.
13. Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, et al. Expression of ral GTPases, their effectors and activators in human bladder cancer. Clin Cancer Res 2007; 13:3803-13; PMID:17606711; http://dx.doi.org/10.1158/1078-0432.CCR-06-2419.
14. Zipfel PA, Brady DC, Kashatus DF, Ancrile BD, Tyler DS, Counter CM. Ral activation promotes melanomagenesis. Oncogene 2010; 29:4859-64; PMID:20562921; http://dx.doi.org/10.1038/onc.2010.224.
15. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013.
16. Wu Z, Owens C, Chandra N, Popovic K, Conaway M, Theodorescu D. RalBP1 is necessary for metastasis of human cancer cell lines. Neoplasia 2010; 12:1003-12; PMID:21170262.
17. Issaq SH, Lim KH, Counter CM. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis. Mol Cancer Res 2010; 8:223-31; PMID:20145037; http://dx.doi.org/10.1158/1541-7786.MCR-09-0189.
18. Cascone I, Selimoglu R, Ozdemir C, Del Nery E, Yeaman C, White M, et al. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. EMBO J 2008; 27:2375-87; PMID:18756269; http://dx.doi.org/10.1038/emboj.2008.166.
19. Shipitsin M, Feig LA. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol Cell Biol 2004; 24:5746-56; PMID:15199131; http://dx.doi.org/10.1128/MCB.24.13.5746-56.2004.
20. Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL, et al. RalBGTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 2006; 127:157-70; PMID:17018283; http://dx.doi.org/10.1016/j.cell.2006.08.034.
21. Bodemann BO, Orvedahl A, Cheng T, Ram RR, Ou YH, Formstecher E, et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 2011; 144:253-67; PMID:21241894; http://dx.doi.org/10.1016/j.cell.2010.12.018.
22. Falsetti SC, Wang DA, Peng H, Carrico D, Cox AD, Der CJ, et al. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth. Mol Cell Biol 2007; 27:8003-14; PMID:17875936; http://dx.doi.org/10.1128/MCB.00057-07.
23. Lim KH, Brady DC, Kashatus DF, Ancrile BB, Der CJ, Cox AD, et al. Aurora-A phosphorylates, activates and relocalizes the small GTPaseRalA. Mol Cell Biol 2010; 30:508-23; PMID:19901077; http://dx.doi.org/10.1128/MCB.00916-08.
24. Wang H, Owens C, Chandra N, Conaway MR, Brautigan DL, Theodorescu D. Phosphorylation of RalB is important for bladder cancer cell growth and metastasis. Cancer Res 2010; 70:8760-9; PMID:20940393; http://dx.doi.org/10.1158/0008-5472.CAN-10-0952.
25. Green MR, Woolery JE, Mahadevan D. Update on Aurora Kinase Targeted Therapeutics in Oncology. Expert Opin Drug Discov 2011; 6:291-307; PMID:21556291; http://dx.doi.org/10.1517/17460441.2011.555395.